FindTrial
Sign In

Quetiapine Extended Release

DRUG4 trials

Sponsors

AstraZeneca, McMaster University, H. Lundbeck A/S

Conditions

Bipolar DepressionDepressionHot FlashesInsomniaMajor Depressive DisorderSchizophrenia

Phase 3

Quetiapine Extended Release Depression Symptoms
CompletedNCT00640562
AstraZenecaDepression, Schizophrenia
Start: 2008-02-29End: 2010-02-28Updated: 2012-06-19
Brexpiprazole in Patients With Acute Schizophrenia
CompletedNCT01810380
H. Lundbeck A/SSchizophrenia
Start: 2013-03-31End: 2014-12-31Updated: 2017-03-16

Phase 4

Quetiapine Extended Release (XR) for the Treatment of Menopausal Depression
CompletedNCT00723970
McMaster UniversityHot Flashes, Insomnia, Major Depressive Disorder
Start: 2007-06-30End: 2009-05-31Updated: 2012-02-08
Study Comparing the Tolerability of Seroquel IR With Seroquel XR in Patients With Bipolar Depression
CompletedNCT00926393
AstraZenecaBipolar Depression
Start: 2009-06-30End: 2009-08-31Updated: 2011-05-11

Related Papers

Effects of Brexpiprazole on Functioning in Patients With Schizophrenia Who Have Hostility and Agitation Symptoms: Post Hoc Analysis of Short- and Long-Term Trials.
2026-07-20
Brexpiprazole for anxiety symptoms in schizophrenia: a pooled analysis of short- and long-term trials.
2025-08-01
Efficacy and safety of brexpiprazole in early-episode schizophrenia: post hoc analysis of clinical trials in adults and adolescents
European Psychiatry2025-04-01
Effects of brexpiprazole on patient life engagement in schizophrenia: <i>post hoc</i> analysis of Positive and Negative Syndrome Scale data.
2025-01-034 citations
Effects of Brexpiprazole on Functioning in Patients With Schizophrenia
The Journal of Clinical Psychiatry2022-02-2810 citations
Effects of Brexpiprazole Across Symptom Domains in Patients With Schizophrenia: <i>Post Hoc</i> Analysis of Short- and Long-Term Studies
Schizophrenia Bulletin Open2021-01-017 citations
M191. EFFECT OF BREXPIPRAZOLE ON ENGAGEMENT IN PATIENTS WITH SCHIZOPHRENIA: POST-HOC ANALYSIS OF THREE STUDIES
Schizophrenia Bulletin2020-04-013 citations
F111. EARLY IMPROVEMENT OF PANSS ITEMS IN PATIENTS WITH SCHIZOPHRENIA TREATED WITH BREXPIPRAZOLE: A POST HOC ANALYSIS OF THREE RANDOMIZED STUDIES
Schizophrenia Bulletin2019-04-01
T50. SYMPTOMATIC AND FUNCTIONAL RESPONSE TO BREXPIP RAZOLE TREATMENT IN PATIENTS WITH ACUTE SCHIZOPHRENIA BY AGE
Schizophrenia Bulletin2018-04-011 citations
O7.5. LONG-TERM SAFETY AND TOLERABILITY OF BREXPIPRAZOLE IN PATIENTS WITH SCHIZOPHRENIA
Schizophrenia Bulletin2018-03-314 citations
An interventional, multi-center, randomized, double-blind, placebo-controlled, active reference, flexible dose study of brexpiprazole in adults with acute schizophrenia
European Psychiatry2016-03-018 citations
Efficacy and safety of brexpiprazole in schizophrenia: Meta-analysis of three double-blind, randomized, placebo-controlled phase 3 studies
European Psychiatry2016-03-011 citations
Treatment of depressive symptoms in patients with schizophrenia
International Clinical Psychopharmacology2014-10-309 citations
Extended-release quetiapine fumarate (quetiapine XR) versus risperidone in the treatment of depressive symptoms in patients with schizoaffective disorder or schizophrenia
International Clinical Psychopharmacology2013-11-266 citations
Self-reported sedation profile of quetiapine extended-release and quetiapine immediate-release during 6-day initial dose escalation in bipolar depression: a multicenter, randomized, double-blind, phase IV study.
2012-10-0815 citations